北方药学
北方藥學
북방약학
JOURNAL OF NORTH PHARMACY
2014年
1期
66-66,67
,共2页
乳腺癌%CA15-3%CA50%CA19-9%IL-8
乳腺癌%CA15-3%CA50%CA19-9%IL-8
유선암%CA15-3%CA50%CA19-9%IL-8
Breast cancer%CA15-3%CA50%CA19-9%IL-8
目的：探讨血清CA15-3、CA50、CA19-9和IL-8检测对乳腺癌患者诊断的临床意义。方法：应用放射免疫法和化学发光法对34例乳腺癌患者（均为女性）进行血清的CA15-3、CA50、CA19-9和IL-8检测，并与34名正常人（均为女性）进行相关对比分析。结果：乳腺癌患者的CA15-3、CA50和IL-8含量水平明显高于对照组（P＜0.05），而CA19-9与正常人对照组无明显差异（P＞0.05）。结论：血清CA15-3、CA50和IL-8的检测对乳腺癌的发病、预防、诊断和治疗均有重要的临床价值。
目的：探討血清CA15-3、CA50、CA19-9和IL-8檢測對乳腺癌患者診斷的臨床意義。方法：應用放射免疫法和化學髮光法對34例乳腺癌患者（均為女性）進行血清的CA15-3、CA50、CA19-9和IL-8檢測，併與34名正常人（均為女性）進行相關對比分析。結果：乳腺癌患者的CA15-3、CA50和IL-8含量水平明顯高于對照組（P＜0.05），而CA19-9與正常人對照組無明顯差異（P＞0.05）。結論：血清CA15-3、CA50和IL-8的檢測對乳腺癌的髮病、預防、診斷和治療均有重要的臨床價值。
목적：탐토혈청CA15-3、CA50、CA19-9화IL-8검측대유선암환자진단적림상의의。방법：응용방사면역법화화학발광법대34례유선암환자（균위녀성）진행혈청적CA15-3、CA50、CA19-9화IL-8검측，병여34명정상인（균위녀성）진행상관대비분석。결과：유선암환자적CA15-3、CA50화IL-8함량수평명현고우대조조（P＜0.05），이CA19-9여정상인대조조무명현차이（P＞0.05）。결론：혈청CA15-3、CA50화IL-8적검측대유선암적발병、예방、진단화치료균유중요적림상개치。
Objective:To investigate the clinical signficance of differences on serum CA15-3,CA50,CA19-9,IL-8 levels detection in patients with breast cancer. Methods:Serum CA15-3,CA50,CA19-9,IL-8 concentration from 34 patients (female) with breast cancer and 34 healthy normal controls (female) were determined by RIA and CLIA. Results:The serum CA15-3,CA50,IL-8 levels in patients with breast cancer were significant higher than those in controls. But the serum CA19-9 levels were no significant difference from those in controls.Conclusion:Detection of serum CA15-3,CA50,IL-8 levels might be of prognostic importance in patients with breast cancer.
